Quality

The focus of quality improvement in healthcare is to bolster performance and processes related to diagnostic and therapeutic procedures. Leaders in this space also ensure the proper selection of imaging exams and procedures, and monitor the safety of services, among other duties. Reimbursement programs such as the Merit-based Incentive Payment System (MIPS) utilize financial incentives to improve quality. This also includes setting and maintaining care quality initiatives, such as the requirements set by the Joint Commission.

Thumbnail

Size matters: How one large radiology provider is using scale to solve the value equation

Leaders at Radiology Partners recently detailed how they’re harnessing their considerable reach to improve care delivery. 

Thumbnail

Top patient safety concerns of 2020

Missed and delayed diagnosis is the top patient safety concern of 2020, according to a new list from ECRI.

Thumbnail

Best hospitals in the world 2020

For the second year in a row, Newsweek has ranked the best hospitals in the world in partnership with global research company Statista.

Thumbnail

Google faces more backlash over health data privacy concerns

Google has been partnering up with healthcare industry titans over the last few years in data exchange contracts that continue to draw criticism, Business Insider reported.

Thumbnail

Two new studies confirm replacing red meat with plant protein lowers risk of dying, heart disease

Another round of studies prove that consuming red and processed meat is bad for health. The studies, both from Harvard researchers, were presented at the American Heart Association’s EPI Scientific Sessions.

Thumbnail

Diabetes drug tainted with carcinogen

A probable carcinogen NDMA has been found in a diabetes drug metformin, testing by a pharmacy has confirmed. The FDA previously announced it was testing metformin, which helps control blood sugar, for NDMA.

Thumbnail

First drug shortage reported from coronavirus

A shortage of a human drug was reported by the FDA as a result of the coronavirus. The agency has been closely monitoring the supply chain in anticipation that the virus, dubbed COVID-19, would lead to potential drug shortages.

Thumbnail

Coronavirus testing kits under investigation

HHS is investigating a potential problem with the first round of diagnostics for coronavirus after fears of contamination at a lab where government tests were sent. Timothy Stenzel, an FDA official and scientist who visited the government lab, sounded the alarm after witnessing procedures that concerned him.